Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.

Shariff, Mohamed I F; Tognarelli, Joshua M; Lewis, Matthew R; Want, Elizabeth J; Mohamed, Fatma El Zahra; Ladep, Nimzing G; Crossey, Mary M E; Khan, Shahid A; Jalan, Rajiv; Holmes, Elaine; Taylor-Robinson, Simon D

Shariff, Mohamed I F; Tognarelli, Joshua M; Lewis, Matthew R; Want, Elizabeth J; Mohamed, Fatma El Zahra; Ladep, Nimzing G; Crossey, Mary M E; Khan, Shahid A; Jalan, Rajiv; Holmes, Elaine; Taylor-Robinson, Simon D.

Shariff MI; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Tognarelli JM; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Lewis MR; Department of Surgery and Cancer, Imperial College London, Division of Computational and Systems Medicine, London SW7 2AZ, United Kingdom.
Want EJ; Department of Surgery and Cancer, Imperial College London, Division of Computational and Systems Medicine, London SW7 2AZ, United Kingdom.
Mohamed Fel Z; Pathology Department, Minia University, Minia, Egypt.
Ladep NG; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, Division of Computational and Systems Medicine, London SW7 2AZ, United Kingdom.
Crossey MM; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, Division of Computational and Systems Medicine, London SW7 2AZ, United Kingdom.
Khan SA; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Jalan R; Department of Medicine, University College London, Royal Free Hospital, London NW3 2QG, United Kingdom.
Holmes E; Department of Surgery and Cancer, Imperial College London, Division of Computational and Systems Medicine, London SW7 2AZ, United Kingdom.
Taylor-Robinson SD; Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.

J Clin Exp Hepatol ; 5(4): 286-94, 2015 Dec.

Article en En | MEDLINE | ID: mdl-26900269

Palabras clave

1-D, one-dimensional; 1H, human proton; CPMG, Carr-Purcell-Meiboom-Gill 3B; DEN, diethylnitrosamine; FID, free induction decay; HCC, hepatocellular carcinoma; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NMOR, N-nitrosomorpholine; NMR spectroscopy; NMR, nuclear magnetic resonance; NOESY, nuclear overhauser effect spectroscopy; PCA, principal components analysis; PLS-DA, partial least squares discriminant analysis; Q2, goodness of prediction; R2, goodness of fit; RD, relaxation delay; RF, radiofrequency; SBP, spontaneous bacterial peritonitis; TLR-4, Toll-like receptor 4; VLDL, very low-density lipoprotein; hepatocellular carcinoma; metabonomics; norfloxacin

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2015 Tipo del documento: Article